Secunderabad Healthcare Ltd.
|BSE: 524540||Sector: Health care|
|NSE: N.A.||ISIN Code: INE930C01016|
|BSE 00:00 | 04 Mar||Secunderabad Healthcare Ltd|
|NSE 05:30 | 01 Jan||Secunderabad Healthcare Ltd|
Secunderabad Healthcare Ltd. (SECUNDHEALTH) - News Sector
7.15 pm | 17 Aug 2022 | Business Standard
Brokerages give add, accumulate or buy ratings given the company's growth and track record
12.21 am | 17 Aug 2022 | Business Standard
KKR sold the entire 26.8% stake worth Rs 9,400 cr as part of its exit strategy
2.04 pm | 16 Aug 2022 | Press Trust of India
Aurobindo Pharma Ltd on Tuesday said its wholly-owned arm Eugia Pharma Specialties Ltd has received final approval from the US health regulator for it...
1.26 am | 16 Aug 2022 | BS Reporter
American PE major exits from hospital chain after acquiring the stake in 2018
1.34 am | 15 Aug 2022 | Press Trust of India
Homegrown pharmaceutical firm Lupin Ltd is rationalising its product portfolio in the US, transitioning from simple oral solid medicines to more compl...
12.44 am | 13 Aug 2022 | Business Standard
This paves the way towards creation of two separate listed entities - Piramal Enterprises and Piramal Pharma
8.27 am | 12 Aug 2022 | Business Standard
The technical analyst from HDFC Securities recommends buying Lupin 700 Call and simultaneously selling 720 Call for the August series.
3.49 pm | 10 Aug 2022 | Press Trust of India
'Q1FY23 performance reflects normalisation of revenues and operating EBITDA post Omicron wave in the previous quarter,' Max Healthcare Chairman and MD...
1.56 am | 9 Aug 2022 | Business Standard
The hospital asset was sold by DLF Qutub Enclave Complex Medical Charitable Trust in 2011 to Nayati Healthcare and Research NCR Pvt Ltd
9.30 pm | 4 Aug 2022 | Press Trust of India
'Our numbers are muted this quarter, but we expect a strong bounce back from Q2 onwards,' says Lupin MD
7.54 am | 3 Aug 2022 | Business Standard
The technical analyst from HDFC Securities said traders should wait for correction to enter fresh longs on the Nifty index.
12.46 pm | 2 Aug 2022 | Business Standard
In an interview, Arun Chandravarkar explains why a company must continue investing in R&D despite the impact on short-term Ebitda
3.46 pm | 1 Aug 2022 | Press Trust of India
'We are on track to achieve retail loan disbursements of Rs 2,500 cr-3,500 cr in Q3FY23,' which is 5-7 times of pre-merger levels, says Piramal Group ...
11.48 pm | 31 Jul 2022 | Business Standard
Focus on key markets to help expand branded formulations business, say experts
10.06 pm | 29 Jul 2022 | Business Standard
Domestic revenue dips 8.4% as Covid-19 share of branded prescription business normalises; North American business up 10% to $155 million
10.00 pm | 29 Jul 2022 | Business Standard
Gross sales up 10.1% YoY to Rs 10,644 cr; EBITDA at Rs 2,884.4 cr, with a margin of 26.8%
5.27 pm | 29 Jul 2022 | Business Standard
Swiggy announced on Friday that it has extended its 'Future of Work' policy and announced a permanent work-from-anywhere for majority of roles.
4.30 pm | 29 Jul 2022 | Press Trust of India
The Mumbai-based company had reported a net profit of Rs 710 crore in the April-June quarter of the last fisca
11.37 pm | 28 Jul 2022 | Business Standard
The DRL stock was down marginally (0.73 per cent) to Rs 4,254 on the BSE on Thursday
6.34 pm | 28 Jul 2022 | Press Trust of India
Other operating income was at Rs 600 crore compared to Rs 50 crore in Q1FY22